Bactiguard Holding AB

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SE0005878741
SEK
16.40
-14.2 (-46.41%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard

1

Poor long term growth as Operating profit has grown by an annual rate -21.39% of over the last 5 years

 
2

Risky -

3

Consistent Underperformance against the benchmark over the last 3 years

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

SEK 531 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.32

stock-summary
Return on Equity

-7.06%

stock-summary
Price to Book

1.76

Revenue and Profits:
Net Sales:
45 Million
(Quarterly Results - Sep 2025)
Net Profit:
-8 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-47.1%
0%
-47.1%
6 Months
-53.14%
0%
-53.14%
1 Year
-76.23%
0%
-76.23%
2 Years
-77.44%
0%
-77.44%
3 Years
-84.08%
0%
-84.08%
4 Years
-91.15%
0%
-91.15%
5 Years
-88.37%
0%
-88.37%

Bactiguard Holding AB for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
3.58%
EBIT Growth (5y)
-21.39%
EBIT to Interest (avg)
-3.44
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.27
Sales to Capital Employed (avg)
0.44
Tax Ratio
22.66%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0

Valuation key factors

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
2.00
EV to EBIT
-31.10
EV to EBITDA
28.93
EV to Capital Employed
1.78
EV to Sales
2.97
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-5.72%
ROE (Latest)
-5.96%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Sep 2025 is -5.60% vs -18.44% in Jun 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Sep 2025 is 7.41% vs -72.34% in Jun 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Jun'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "45.50",
          "val2": "48.20",
          "chgp": "-5.60%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "3.30",
          "val2": "1.80",
          "chgp": "83.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "2.60",
          "val2": "2.50",
          "chgp": "4.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-7.50",
          "val2": "-8.10",
          "chgp": "7.41%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-184.50%",
          "val2": "-205.30%",
          "chgp": "2.08%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 19.95% vs -9.88% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 78.47% vs -161.63% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "241.70",
          "val2": "201.50",
          "chgp": "19.95%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "5.30",
          "val2": "-88.70",
          "chgp": "105.98%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "15.60",
          "val2": "13.50",
          "chgp": "15.56%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-7.30",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-29.80",
          "val2": "-138.40",
          "chgp": "78.47%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-166.30%",
          "val2": "-656.90%",
          "chgp": "49.06%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQstock-summary

Sep'25
Jun'25
Change(%)
Net Sales
45.50
48.20
-5.60%
Operating Profit (PBDIT) excl Other Income
3.30
1.80
83.33%
Interest
2.60
2.50
4.00%
Exceptional Items
0.00
0.00
Consolidate Net Profit
-7.50
-8.10
7.41%
Operating Profit Margin (Excl OI)
-184.50%
-205.30%
2.08%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Sep 2025 is -5.60% vs -18.44% in Jun 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Sep 2025 is 7.41% vs -72.34% in Jun 2025

Annual Results Snapshot (Consolidated) - Dec'24stock-summary

Dec'24
Dec'23
Change(%)
Net Sales
241.70
201.50
19.95%
Operating Profit (PBDIT) excl Other Income
5.30
-88.70
105.98%
Interest
15.60
13.50
15.56%
Exceptional Items
0.00
-7.30
100.00%
Consolidate Net Profit
-29.80
-138.40
78.47%
Operating Profit Margin (Excl OI)
-166.30%
-656.90%
49.06%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 19.95% vs -9.88% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 78.47% vs -161.63% in Dec 2023

stock-summaryCompany CV
About Bactiguard Holding AB stock-summary
stock-summary
Bactiguard Holding AB
Pharmaceuticals & Biotechnology
Bactiguard Holding AB is a Sweden-based company engaged in the development of solutions for preventing of device-related healthcare associated infections (HAI). Its technology is based on the Bactiguard Infection Protection (BIP), a thin coating permanently bound to the surface of medical devices. It consists of the noble metals: gold, palladium and silver, which reduces the adhesion of bacteria to the coated surfaces. Its product portfolio includes: BIP Foley Catherer, made from medical grade latex, and BIP Foley Catheter - Silicone, used for drainage and irrigation of the bladder; BIP Endotracheal Tube, for general anesthesia, intensive care, and emergency medicine for airway management and mechanical ventilation; and BIP Central Venous Catherer, made of polyurethane and used to administer drugs and intravenous solutions, monitor pressure and blood sampling. The Company is also present in Portugal, via a distribution agreement with Socime Medical Ltd, and Zambia.
Company Coordinates stock-summary
Company Details
Biblioteksgatan 25 , STOCKHOLM None : 114 35
Registrar Details